Polish Multicenter PERTs PE Outcomes Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPoznan University of Medical Sciences
About this trial
Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
PE confirmed by computed tomography pulmonary angiography.
PE symptoms duration ≤ 14 days.
cardiac arrest
obstructive shock
Disqualifiers
None
Trial population
Consecutive patients hospitalized due to high-risk or intermediate-high risk PE.
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 2 trial groupsGroup A: Intermediate-high risk PE
Group B: High-risk PE
Trial outcomes
Primary outcomes
1
Clinical improvement during hospitalization
Incidence of arterial blood saturation increase \>92%
Time frame
24 hours after specific PE treatment implementation2
Ventricular strain reduction
Rate of right ventricular strain reduction (right ventricle/left ventricle ratio assessment) in echocardiography
Time frame
24 hours after specific PE treatment implementation3
Early mortality rate from pulmonary embolism
Number of patients who died from pulmonary embolism (right heart failure)
Time frame
Two weeks since PE diagnosisSecondary outcomes
1
Total mortality rate from pulmonary embolism
Number of patients who died from pulmonary embolism (right heart failure)
Time frame
3 months since PE diagnosis2
Bleeding events incidence
Incidence of major bleedings assessed using ISTH criteria
Time frame
3 months since PE diagnosisSponsors and contacts
Click on the lead sponsor to view all of their trials.
Poznan University of Medical Sciences
Lead sponsor
Polish Cardiac Society
Collaborator
Source ClinicalTrials.gov